Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lenka Zdrazilova-Dubska

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|May 12, 2018
Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatmentKaterina Pilatova, Beatrix Bencsikova, Regina Demlova, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 9, 2018
Host-dependent variables: The missing link to personalized medicineRegina Demlova, Lenka Zdrazilova-Dubska, Jaroslav Sterba, et al.
Journal of Medical Virology|October 20, 2020
Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMIIveta Selingerova, Dalibor Valik, Lenka Gescheidtova, et al.
International Immunopharmacology|July 10, 2019
Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threateningJiri Vyskocil, Stepan Tucek, Igor Kiss, et al.
Biomed Research International|September 5, 2015
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaMichal Rihacek, Julie Bienertova-Vasku, Dalibor Valik, et al.
Journal of Hematology & Oncology|June 27, 2013
Role of platelet chemokines, PF-4 and CTAP-III, in cancer biologyKaterina Pilatova, Kristina Greplova, Regina Demlova, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2019
High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impactRadka Obermannova, Dalibor Valik, Dirk Hasenclever, et al.
Ticks and Tick-Borne Diseases|February 14, 2016
'Candidatus Rickettsia mendelii', a novel basal group rickettsia detected in Ixodes ricinus ticks in the Czech RepublicEva Hajduskova, Ivan Literak, Ivo Papousek, et al.
Frontiers in Microbiology|February 18, 2026
Emergence and genomic characterization of hypervirulent ST23/K1 <i>Klebsiella pneumoniae</i>: local epidemiology and global contextMatej Bezdicek, Marketa Jakubickova, Viktoria Bitusikova, et al.
BMC Gastroenterology|April 19, 2015
Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical viewBeatrix Bencsikova, Zbynek Bortlicek, Jana Halamkova, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|May 12, 2018
Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatmentKaterina Pilatova, Beatrix Bencsikova, Regina Demlova, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 9, 2018
Host-dependent variables: The missing link to personalized medicineRegina Demlova, Lenka Zdrazilova-Dubska, Jaroslav Sterba, et al.
Journal of Medical Virology|October 20, 2020
Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMIIveta Selingerova, Dalibor Valik, Lenka Gescheidtova, et al.
International Immunopharmacology|July 10, 2019
Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threateningJiri Vyskocil, Stepan Tucek, Igor Kiss, et al.
Biomed Research International|September 5, 2015
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaMichal Rihacek, Julie Bienertova-Vasku, Dalibor Valik, et al.
Journal of Hematology & Oncology|June 27, 2013
Role of platelet chemokines, PF-4 and CTAP-III, in cancer biologyKaterina Pilatova, Kristina Greplova, Regina Demlova, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2019
High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impactRadka Obermannova, Dalibor Valik, Dirk Hasenclever, et al.
Ticks and Tick-Borne Diseases|February 14, 2016
'Candidatus Rickettsia mendelii', a novel basal group rickettsia detected in Ixodes ricinus ticks in the Czech RepublicEva Hajduskova, Ivan Literak, Ivo Papousek, et al.
Frontiers in Microbiology|February 18, 2026
Emergence and genomic characterization of hypervirulent ST23/K1 <i>Klebsiella pneumoniae</i>: local epidemiology and global contextMatej Bezdicek, Marketa Jakubickova, Viktoria Bitusikova, et al.
BMC Gastroenterology|April 19, 2015
Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical viewBeatrix Bencsikova, Zbynek Bortlicek, Jana Halamkova, et al.
Pageof 3